📌 Key Takeaways
- Topic: Silica Polishing Slurry: How It Works, Particle Sizes and Applications
- Keywords: silica gel beads
- Published: 2026-11-20 03:44:13
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Ryoo, R., Kim, J., Ko, C. & Shin, C. Disordered molecular sieve with branched mesoporous channel network. J. Phys. Chem. 100, 17718-17721 (1996). Piece CAS Google Scholar
Cab-O-Sil M-5: Specifications, Uses and Equivalent Fumed Silica Grades
- Mica Powder vs Silica: Properties and Applications Compared
- Sun, K. et al. Improved highly toxic reactive oxygen species levels from iron oxide core-shell mesoporous silica nanocarrier-mediated Fenton reactions for cancer therapy. J. Mater. Chem. B 6, 5876-5887 (2018). Piece CAS PubMed Google Scholar
- Silica Whiteness: How It Is Measured and Why It Matters for Coatings and Rubber
- Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.
- Silica Supplier Japan: Leading Producers and High-Purity Sourcing Options
- How to Buy Fumed Silica: Grade Selection, Sampling and Supplier Evaluation
- For carbon-based nanomaterials, they can serve as photothermal agents for photothermal antibacterial and photothermal tumor ablation due to their broad-spectrum light-absorption properties. 235, 236, 237, 238 Nevertheless, the disadvantages such as poor solubility and negative material-biological interface interactions limit their further applications. 239, 240 To address this issue, MSNs-coated carbon-based nanomaterials have been produced. Such-constructed nanocomposites not only improve the surface interface properties of carbon-based materials, but also combine the perks of two different drug carriers, including the enhanced water solubility and dispersibility, easier surface functionalization properties and higher drug loading and delivery performance. 219, 241 Another problematic facet of carbon-based materials is that their in vivo biodegradability is difficult to manipulate, which may bring some potential long-term physiological toxicity issues. 242 In tumor therapy, although NPs smaller than 5.5 nm can typically be cleared from the body by the renal metabolic system, particle sizes too small to be enriched to tumor sites by the enhanced permeability and retention (EPR) influence when performing administration intravenously. 243, 244, 245 For this reason, researchers can use the MSNs with outstanding biodegradable properties to address these issues of carbon-based nanomaterials. 229 A recent study demonstrated that by coating a carbon layer on the surface of dendritic degradable MSNs, accelerated degradation of MSNs and collapse of the surface carbon layer could be observed with NIR irradiation. This carbon-silica nanocomposite was swiftly cleared from the body after completion of a synergistic PTT and PDT. 229
Silicon Dioxide in Supplements: Purpose, Safety and Dosage Limits
What is silica (SiO₂)?
silicon dioxide physical properties Yu, L., Lin, H., Lu, X. & Chen, Y. Multifunctional mesoporous silica nanoprobes: Material chemistry-based fabrication and bio‐imaging functionality. Adv. Ther. 1, 1800078 (2018). Article Google Scholar
What is the difference between fumed silica and precipitated silica?
Aerosil R972 Croissant, J. G., Butler, K. S., Zink, J. I. & Brinker, C. J. Synthetic amorphous silica nanoparticles: Toxicity, biomedical and environmental implications. Nat. Rev. Mater. 5, 886-909 (2020). Article CAS Google Scholar
What drives silica raw material prices?
bulk silica powder Wang, J., Jiao, Y. & Shao, Y. Mesoporous silica nanoparticles for dual-mode chemo-sonodynamic therapy by low-energy ultrasound. Materials 11, 2041 (2018). Piece PubMed Central PubMed Google Scholar
Cite this article: Silica Raw Materials News. "Electronic Grade Silica: Purity Requirements, Specifications and Applications
." Published 2026-11-20 03:44:13.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.